NeuroOne Medical Technologies Corporation NMTC 深 沪
等待开盘 03-26 09:30:00 美东时间
0.77
+0.010
+1.32%
华盛通- 最 高0.7899
- 今 开0.779
- 成交量 10.34万股
- 最 低 0.7655
- 昨 收 0.76
- 总市值 3903.36万
- 52周最高 1.16
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.3954
- 委 比 98.67%
- 总股本 5069.30万
- 历史最高 7.97
- 量 比 0.82
- 振 幅 3.21%
- 历史最低 0.3954
- 每 手 1
- 风险率 0.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Edesa Biotech (NASDAQ:EDSA) shares rose 61.0% to $3.67 during Tuesday'...
03-04 01:05
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5
Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.5.
03-02 21:12
Insights into NeuroOne Medical Tech Q1 Earnings
NeuroOne Medical Tech (NASDAQ:NMTC) just disclosed its Q1 earnings on Tuesday, ...
02-17 21:02
NeuroOne Medical Tech Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $2.893M Beat $2.678M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 150 percent decrease over earnings of $0.06 per share from
02-17 21:01
NeuroOne reports no license revenue in Q1 as prior-year figure was USD 3.0 million
NeuroOne reports no license revenue in Q1 as prior-year figure was USD 3.0 million NeuroOne Medical Technologies Corporation reported its earnings for the three months ended December 31, 2025. The company generated no license revenue for the period, following license revenue of USD 3.0 million in th
02-17 20:03
Earnings Scheduled For February 17, 2026
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likel...
02-17 19:11
What to Expect from NeuroOne Medical Tech's Earnings
NeuroOne Medical Tech (NASDAQ:NMTC) is preparing to release its quarterly earni...
02-17 05:01
NeuroOne plans 2026 drug delivery commercialization as Q4 product revenue jumps 907%
Earnings Call Insights: NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Management View CEO David Rosa stated that fiscal year 2025 was the most successful in the company's history and an inf...
2025-12-18 00:20
NeuroOne Medical Tech Q4 EPS $(0.04), Inline, Sales $2.741M Beat $2.470M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 63.64 percent increase over losses of $(0.11) per share from the same period last
2025-12-17 19:40
